Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This study uses a computerized method of musical instrument digital interface (MIDI)
quantification of performance before and after treatment with botulinum toxin type B (Myobloc
®, Solstice Neurosciences). Myobloc is a purified and diluted form of botulinum toxin used
medically to relax unwanted muscle spasms and movements. The aim of the study is to determine
the feasibility of quantifying change in performance following treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Columbia University
Collaborator:
Solstice Neurosciences
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA rimabotulinumtoxinB